Finally, IPOS takes place as an old fashioned meeting with friends, colleagues and listening to science - the standard of studies have increased immensely - I enjoy #IPOS2022

Following three intensive days on #IPOS2022 we are@on the way to cross the Atlantic, see you at #ipos2023 in Milan

Presenting PROTECT, Stick Together, ACT and PreventDep we are heading back from #ipos2022 see you in Milan to #ipos2023

Goodbye Toronto - thank you #IPOS #CAPO for a conference with strong research and inspiring talks - see you at #IPOS2023 in Milan! linkedin.com/posts/castle-r…

No observable impact of #CellPhone #MobilePhone📱 #EMF on #glioma incidence rates in Nordic countries according to new study by IARC researchers & partners. Article in Environment International evaluates evolution of incidences rates in these countries in 1979-2016 iarc.who.int/news-events/ti…

Hvem er CASTLE og hvad forsker vi i? Vi fortsætter rækken af portrætter af forskerne på CASTLE. Læs med på Linkedin! Denne gang om Bolette Skjødt Rafn linkedin.com/feed/update/ur…

Opening of the European Cancer Rehabilitation Survivorship Symposium Christoffer Johansen Jesper Fisker Marianne Nord Hansen Acta Oncologica Kræftens Bekæmpelse Exciting program and important focus on late effects over the next two days in Copenhagen! #ECRS2022

European Cancer Rehabilitation and Survivorship Symposium 2022 has started. Looking forward to learning a lot over the next 2 days. Kræftens Bekæmpelse #ECRS2022 Acta Oncologica Jesper Fisker Christoffer Johansen

A great talk on #screening for #ProstateCancer by Anssi Auvinen during #ECRS. Pinpointing perfectly the pro's and con's of screening. My take-away: we need evidence on risk stratified and mri based screening before implementation. Kræftens Bekæmpelse

ECRS 2022 Copenhagen focusing on survivorship issues including interventions from screening to clinical follow-up, exercise, PROMs, rehabilitation and more.

A symposium focused on very important topics for #cancer manegement with a focus on patient health! We are very glad to participate and contribute. Kræftens Bekæmpelse Signe Benzon Larsen #ECRS #ECRS2022

Now our road trip has a pit stop at Hindsgavl for a day on late effects. The CEO of the Danish Cancer Society is taking care of the opening

De to hundrede deltagere siger velkommen til mit indlæg om CASTLE - hvad laver vi og hvor er fremtiden. DCCC Kræftens Bekæmpelse #dkpol #sundpol

Important update on evidence base and first(!) Danish clinical guidelines for monitoring and treatment of lymphedema after breast cancer with DBCG presented by Bolette Skjødt Rafn at Bedre Viden om Senfølger late effects seminar today. PROTECTtrial funded by @trygfonden will inform guideline-update

Enjoying day 1 of our first (hopefully of many) seminar on Cancer and Metabolism with fantastic speakers and poster teamwork by Emma Helene Frank Larsen Steffen H. Raun Mona Ali @DDA_Denmark @BiomedUCPH

The Danish Diabetes Academy workshop onDiabetes and Metabolism - this time with a focus on cancer. BeingRoyal Danish Academy for Sciences and ...Letters (?) - our forefarthers are participating..

Sometimes CASTLE actually learn and even enjoy learning - the two days at @DDA_Denmark. Together with colleagues from different backgrounds including Bente Klarlund and Signe Borgquist it opened up for ideas. Thanks to organizers Lykke Sylow Louise Lang Lehrskov Tinne Laurberg

Follow-up for cancer is changing! We argue that follow-up should be patient-, not calendar-driven, and focus on late effects, not recurrence. Read our editorial in Acta Oncologica #survivorship #lateeffects @senfoelger …-tandfonline-com.ep.fjernadgang.kb.dk/doi/full/10.10…

Editorial about changing cancer-follow-up is out! With Christoffer Johansen Bolette Skjødt Rafn Signe Borgquist Peer Christiansen Peter Christensen Bobby Zachariae Helle Pappot Ulrik Lassen